Indian equities are poised for a constructive phase, with strategists anticipating earnings acceleration and a potential revival in foreign investor interest. While near-term earnings surprises are limited, FY27 is projected to see significant growth. Pharma is favored over IT, with selective opportunities in midcaps and other sectors.
Markets in limbo as US–Iran uncertainty clouds global outlook: Geoff Dennis
Global markets are grappling with US-Iran standoff uncertainty, with conflicting signals leaving investors hesitant. Despite geopolitical tensions, oil prices remain below extreme forecasts, cushioning global
June 1, 2026